9:00 – 9:10 

Welcome & introduction
Steven Harsono, Head of Public Health, Asia Pacific, IQVIA

9:10 – 9:30

Opening address 
Dr. Anand Tharmaratnam, President, Asia Pacific, IQVIA

9:30 – 10:00

Data Science: then & now
Data has become one of the most valuable assets in an organization and data science is the key to unlocking its latent potential. We explore data science’s journey in transforming the healthcare industry & look at what the future holds in the exciting area. 
Nawal Roy, Founder & Chief Executive Officer, Holmusk

10:00 – 10:30

The future of healthcare in Asia Pacific: what’s next?
With half the world’s population and the second largest Pharma market, Asia Pacific as a region is the most dynamic of the global economy and continues to rise in prominence. With increasing investment, innovation and digitization across industries, how do we see the future of healthcare evolving in Asia Pacific?  
Abrar Mir, Founder and Managing Partner, Quadria Capital

10:45 – 11:15

Building consumers from patients: the Asia experience
As the Asia self-care market grows rapidly, how should Consumer Health companies build and adapt the ecosystem and services required to help the new informed consumer optimize their wellness goals? We deep-dive into ‘The Asia experience’ and take a look at what the Healthcare companies should be doing differently to delight the evidence-seeking fast-moving consumer health customer

Moderator:
Jude Uzonwanne, Principal, Consulting Group, Asia Pacific,  IQVIA
Panellists:
Carla Speering, Director of Marketing Self Care “New Growth Areas”, Asia Pacific, Johnson & Johnson
Peter Condron, Head of Data Science, Danone Precision Nutrition D-Lab
Stéphane Jacqmin, Head of Consumer Healthcare, South East Asia & China, Sanofi Consumer Healthcare

11:15 – 11:45

11:45 – 12:15

Asia Pacific’s digital journey towards customer centricity
‘Customer centricity’ has moved from being a buzz-word to becoming a reality in how companies deploy healthcare strategies and operations. We discuss the role digital applications play in enabling and empowering healthcare companies to function as customer-centric organizations 

Moderator:
Jonathan Foster, Practice Leader, Technologies, Asia Pacific, IQVIA
Panellists:
Glenn Cross, Head of Commercial Execution, APMA, Novartis
John Cairns, Head of Multi-Channel Engagement and Digital Innovation, Asia, Sanofi

Breakout Sessions:

Track 1: Virtual is the new reality

Track 2: Technology transforming healthcare

Track 3: China in Focus

13:15 – 13:45

China: future shaping 
With its first home grown Oncology drug approved this year & with the world’s second largest pharma market China is undoubtedly a ‘mover and shaker’ of Asia and at the same time is seeing rapid change. How then do we crack the ‘China code’? We take a look at key trends and market drivers, regulatory updates and future outlook. We also explore the biopharma boom and its impact on the industry

Dr. Tong Guo, Vice President & Head of Business Development, Greater China, IQVIA

13:45 – 14:15

14:25 – 15:00

Rise of the virtual rep
China, like several countries in Asia, faces challenges related to long distances, compliance, remote access & infrastructure, making accessibility a concern. However, the technology boom in Asia has ensured that innovative tech solutions are overcoming these barriers. We unveil the latest in ‘virtual reps’ technology to ensure effective and efficient HCP engagements. 

Dr. Kings Wang, Senior Director, Strategic Planning & Business Development, Head of Contract Sales & Medical Service, Greater China, IQVIA

15:30 – 16:15

Asia Pacific c-suite roundtable | Biotech’s role in shaping the future of Asian healthcare 
Over the past decade, SEA has seen a rise in the number of innovative ‘home-grown’ biotech. What has led to their growth and success, what are some challenges they face and what to look out for while navigating the complex landscape? We speak to some of Asia Pacific’s top biotech CEOs to hear their views on how biotech will shape the future of Asian Healthcare

Moderator:
Bhavani Sivalingam, Senior Vice President, R&D Solutions, Asia Pacific, IQVIA
Panellists:
Dr. Anil Ratty, Chairman &  Chief Executive Officer, Cennerv Pharma
Dr. Carl Firth, Chief Executive Officer, Aslan Pharmaceuticals
Dr. Charles Stacey, President & Chief Executive Officer, Cerecin.

16:15 – 16:55

Personalized medicine: Human Data Science at its best [Keynote panel]
Personalized medicine is the frontier of healthcare and we have begun making inroads. In our keynote panel, we explore how data science applications are being used to further genetic profiling, targeted therapies, pharmacogenomics and more, in finally delivering personalized healthcare to individual patients 

Moderator:
Dr. Senthil Sockalingam, Vice President, Head of Real World Insights, Asia Pacific, IQVIA
Panellists:
Colin Albert, Chief Executive Officer, genomiQa
Danny Yeung, Chief Executive Officer, Prenetics
Nawal Roy, Founder & Chief Executive Officer, Holmusk
Richard Batchelder, Commercial Director for Personalized Health, Market Development, Roche

16:55 – 17:00